Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D

被引：0
|
作者：
S. M. H. Alibhai
H. Z. Mohamedali
H. Gulamhusein
A. H. Panju
H. Breunis
N. Timilshina
N. Fleshner
M. D. Krahn
G. Naglie
I. F. Tannock
G. Tomlinson
P. Warde
S. Duff Canning
A. M. Cheung
机构：
[1] University Health Network,Department of Medicine
[2] Toronto Rehabilitation Institute,Geriatric Program
[3] University of Toronto,Department of Medicine
[4] University of Toronto,Institute of Health Policy, Management and Evaluation
[5] University Health Network,Division of Urology
[6] Baycrest Geriatric Health Care Centre,Department of Medicine and Rotman Research Institute
[7] University of Toronto,Department of Public Health Sciences
[8] University Health Network,Radiation Medicine Program, Princess Margaret Hospital
[9] University Health Network,Neurosciences Program
来源：
Osteoporosis International | 2013年 / 24卷
关键词：
Androgen deprivation therapy; Bone mineral density; Calcium; Osteoporosis; Prostate cancer; Side effects; Vitamin D;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2571 / 2579
页数：8
相关论文
共 50 条
  • [41] Differing Effects of Zoledronic Acid on Bone Microarchitecture and Bone Mineral Density in Men Receiving Androgen Deprivation Therapy: A Randomized Controlled Trial
    Cheung, Ada S.
    Hoermann, Rudolf
    Ghasem-Zadeh, Ali
    Tinson, Alistair J.
    Ly, Vivian
    Milevski, Stefan, V
    Joon, Daryl Lim
    Zajac, Jeffrey D.
    Seeman, Ego
    Grossmann, Mathis
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 (10) : 1871 - 1880
  • [42] Bone mineral density testing after initiation of androgen deprivation therapy for prostate cancer
    Hu, Jason
    Dragomir, Alice
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 521 - 521
  • [43] The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy
    Israeli, Ron S.
    Rosenberg, Steven J.
    Saltzstein, Daniel R.
    Gottesman, James E.
    Goldstein, Howard R.
    Hull, Gerald W.
    Tran, Diep N. H.
    Warsi, Ghulam M.
    Lacerna, Leo V.
    CLINICAL GENITOURINARY CANCER, 2007, 5 (04) : 271 - 277
  • [44] Determinants of vitamin D levels in men receiving androgen deprivation therapy for prostate cancer
    Mennen-Winchell, Lori J.
    Grigoriev, Victor
    Alpert, Patricia
    Dos Santos, Hildemar
    Tonstad, Serena
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2015, 27 (01) : 39 - 47
  • [45] Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy
    Bruder, JM
    Ma, JZ
    Basler, JW
    Welch, MD
    UROLOGY, 2006, 67 (01) : 152 - 155
  • [46] Contemporary Population-Based Analysis of Bone Mineral Density Testing in Men Initiating Androgen Deprivation Therapy for Prostate Cancer
    Hu, Jason
    Aprikian, Armen G.
    Vanhuyse, Marie
    Dragomir, Alice
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (10): : 1374 - +
  • [47] CONTEMPORARY POPULATION-BASED ANALYSIS OF BONE MINERAL DENSITY TESTING IN MEN INITIATING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
    Hu, Jason
    Aprikian, Armen
    Vanhuyse, Marie
    Dragomir, Alice
    JOURNAL OF UROLOGY, 2020, 203 : E963 - E964
  • [48] Bone mineral density testing and the risk of fractures in men initiating androgen-deprivation therapy: Population-based study
    Hu, Jason
    Aprikian, Armen G.
    Dragomir, Alice
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 238 - 238
  • [49] Vitamin D and bone mineral density
    D. Collins
    C. Jasani
    I. Fogelman
    R. Swaminathan
    Osteoporosis International, 1998, 8 : 110 - 114
  • [50] Vitamin D and bone mineral density
    Collins, D
    Jasani, C
    Fogelman, I
    Swaminathan, R
    OSTEOPOROSIS INTERNATIONAL, 1998, 8 (02) : 110 - 114
12345